Clinical

Dataset Information

0

A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy


ABSTRACT: The objective of this study is to compare the progression free survival (PFS), overall survival (OS), objective response rate (ORR), time to treatment failure (TTF), duration of response (DoR), quality of life, safety and tolerability of tivozanib in combination with mFOLFOX6 and bevacizumab in combination with mFOLFOX6.

DISEASE(S): Colorectal Cancer Stage Iv,Colorectal Cancer,Colorectal Neoplasms,Metastatic Colorectal Cancer (crc)

PROVIDER: 2116197 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2023-07-05 | GSE235917 | GEO
2023-07-05 | GSE235919 | GEO
| 2215487 | ecrin-mdr-crc
| 2051414 | ecrin-mdr-crc
| 2752784 | ecrin-mdr-crc
| 2120245 | ecrin-mdr-crc
| 2373570 | ecrin-mdr-crc
2014-09-30 | E-GEOD-32872 | biostudies-arrayexpress
2014-09-30 | GSE32872 | GEO
2023-10-19 | GSE241876 | GEO